Evaluation of a GPIIb/IIIa antagonist YM337 in a primate model of middle cerebral artery thrombosis

By Kaku S.   Umemura K.   Mizuno A.   Yano S.   Suzuki K.-i.   Kawasaki T.   Nakashima M.  

European Journal of Pharmacology, Vol. 345, Iss. 2, 1998-03 ,pp. : 185-192

Elsevier

Access to resources Recommend Favorite

Synergistic effect of aurintricarboxylic acid and triflavin in a photochemically induced thrombosis model in rats

By Hisamichi N.   Kawasaki T.   Suzuki K.-i.   Kaku S.   Sakai Y.   Taniuchi Y.   Sato K.   Inagaki O.   Tomioka K.   Yanagisawa I.   Takenaka T.   Yanagi K.   Ohshima N.  

European Journal of Pharmacology, Vol. 312, Iss. 1, 1996-09 ,pp. : 69-73

Elsevier

Access to resources Recommend Favorite

The effects of bosentan on cerebral blood flow and histopathology following middle cerebral artery occlusion in the rat

By McAuley M.A.   Breu V.   Graham D.I.   McCulloch J.  

European Journal of Pharmacology, Vol. 307, Iss. 2, 1996-06 ,pp. : 171-181

Elsevier

Access to resources Recommend Favorite

Repeated edaravone treatment reduces oxidative cell damage in rat brain induced by middle cerebral artery occlusion

By Yamamoto Yorihiro   Yanagisawa Makoto   Tak Nyou Wei   Watanabe Kazutoshi   Takahashi Chizuko   Fujisawa Akio   Kashiba Misato   Tanaka Masahiko  

Redox Report, Vol. 14, Iss. 6, 2009-12 ,pp. : 251-258

Maney Publishing

Access to resources Recommend Favorite

Antithrombotic efficacy of RPR208566, a novel factor Xa inhibitor, in a rat model of carotid artery thrombosis

By Heran C.   Morgan S.   Kasiewski C.   Bostwick J.   Bentley R.   Klein S.   Chu V.   Brown K.   Colussi D.   Czekaj M.   Perrone M.   Leadley R.  

European Journal of Pharmacology, Vol. 389, Iss. 2, 2000-02 ,pp. : 201-207

Elsevier

Access to resources Recommend Favorite